2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
80
Thoracic
13
Breast
9
Gynecologic
8
NET
6
Endocrine
6
Head & Neck
5
Genitourinary
5
Dermatologic
5
Classical hematology
3
Sarcoma
2
Lymphoid
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Brain Neoplasms
2306
Glioblastoma
2010
Glioma
1397
Central Nervous System Neoplasms
692
Astrocytoma
667
Neuroblastoma
647
Gliosarcoma
480
Neoplasms
405
Oligodendroglioma
404
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
254
Meningioma
229
Recurrence
223
Sarcoma
214
Melanoma
206
Neoplasm Metastasis
202
Lung Neoplasms
198
Ependymoma
198
Neurofibromatosis 1
169
Lymphoma
161
Meningeal Carcinomatosis
138
Osteosarcoma
134
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
106
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Intestinal Neoplasms
×
CNS
×
Clear all
NCT04755920
2024-05-09
SGM-CBM
Leiden University Medical Center
Phase 2
Recruiting
10 enrolled
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts